David R. Liu insider trades
Open-market stock purchases and sales by David R. Liu, 10% Owner at Prime Medicine, Inc, from SEC Form 4 filings since Oct 24, 2022.
Track record: 100% of 4 scored buys are up 5% or more since purchase, averaging +60%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- PRME Prime Medicine, Inc: 4 buys, last Jun 30, 2025